Pursuing progress against childhood leukemia! 💛 #StandUpToCancer recently announced that Caitlin Zebley of StJude Research is the recipient of the 2026 SU2C Maverick Early Career Scientist Award (presented earlier this year by SU2C Scientific Advisory Chair Dr. William G. Nelson). Funding from the award will support Dr. Zebley’s ongoing research to develop effective CAR T-cell therapies for children with acute myelogenous leukemia (AML). Congratulations, Dr. Zebley! Learn more about the award and Dr. Zebley’s research at SU2C.link/MaverickAward. #ChildhoodCancerAwarenessMonth